Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open‐Label Transition From Reference Infliximab to Biosimilar Infliximab
Tweehuysen, Lieke, Bemt, Bart J. F., Ingen, Iris L., Jong, Alphons J. L., Laan, Willemijn H., Hoogen, Frank H. J., Broeder, Alfons A.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.01.2018)
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.01.2018)
Get full text
Journal Article
The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study
Verhoef, Lise M, Selten, Ellen M H, Vriezekolk, Johanna E, de Jong, Alphons J L, van den Hoogen, Frank H J, den Broeder, Alfons A, Hulscher, Marlies E
Published in Rheumatology (Oxford, England) (01.11.2018)
Published in Rheumatology (Oxford, England) (01.11.2018)
Get full text
Journal Article
Tailored cognitive–behavioral therapy and exercise training for high‐risk patients with fibromyalgia
van Koulil, Saskia, van Lankveld, Wim, Kraaimaat, Floris W., van Helmond, Toon, Vedder, Annemieke, van Hoorn, Hanneke, Donders, Rogier, de Jong, Alphons J. L., Haverman, Joost F., Korff, Kurt‐Jan, van Riel, Piet L. C. M., Cats, Hans A., Evers, Andrea W. M.
Published in Arthritis care & research (2010) (01.10.2010)
Published in Arthritis care & research (2010) (01.10.2010)
Get full text
Journal Article
Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis
ten Klooster, Peter M, Vonkeman, Harald E, Taal, Erik, Siemons, Liseth, Hendriks, Lidy, de Jong, Alphons J L, Dutmer, Ellen A J, van Riel, Piet L C M, van de Laar, Mart A F J
Published in Health and quality of life outcomes (08.05.2013)
Published in Health and quality of life outcomes (08.05.2013)
Get full text
Journal Article
A clinical and serological comparison of group A versus non-group A streptococcal reactive arthritis and throat culture negative cases of post-streptococcal reactive arthritis
Jansen, Tim L Th A, Janssen, Matthijs, Traksel, Rene, de Jong, Alphons J L
Published in Annals of the rheumatic diseases (01.07.1999)
Published in Annals of the rheumatic diseases (01.07.1999)
Get full text
Journal Article
Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas
Douglas, B R, Woutersen, R A, Jansen, J B, de Jong, A J, Rovati, L C, Lamers, C B
Published in Gastroenterology (New York, N.Y. 1943) (01.02.1989)
Published in Gastroenterology (New York, N.Y. 1943) (01.02.1989)
Get more information
Journal Article
Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas
DOUGLAS, B. R, WOUTERSEN, R. A, JANSEN, J. B. M. J, DE JONG, A. J. L, ROVATI, L. C, LAMERS, C. B. H. W
Published in Cancer research (Chicago, Ill.) (01.05.1989)
Get full text
Published in Cancer research (Chicago, Ill.) (01.05.1989)
Journal Article
The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats
Jansen, Jan B.M.J., de Jong, Alphons J.L., Lamers, Cornelis B.H.M.
Published in Regulatory peptides (01.02.1989)
Published in Regulatory peptides (01.02.1989)
Get full text
Journal Article
Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs
Jansen, J B, de Jong, A J, Singer, M V, Niebel, W, Rovati, L C, Lamers, C B
Published in Digestive diseases and sciences (01.09.1990)
Published in Digestive diseases and sciences (01.09.1990)
Get more information
Journal Article